These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12827033)

  • 21. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
    Uzu T; Sakaguchi M; Yokomaku Y; Kume S; Kanasaki M; Isshiki K; Araki SI; Sugiomoto T; Koya D; Haneda M; Kashiwagi A
    Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy.
    Matos JP; de Lourdes Rodrigues M; Ismerim VL; Boasquevisque EM; Genelhu V; Francischetti EA
    Clin Nephrol; 2005 Sep; 64(3):180-9. PubMed ID: 16175942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group.
    Howe P; Phillips P; Saini R; Kassler-Taub K
    Clin Exp Hypertens; 1999 Nov; 21(8):1373-96. PubMed ID: 10574419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
    Fukuda M; Yamanaka T; Mizuno M; Motokawa M; Shirasawa Y; Miyagi S; Nishio T; Yoshida A; Kimura G
    J Hypertens; 2008 Mar; 26(3):583-8. PubMed ID: 18300871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.
    Giles TD; Alessi T; Purkayastha D; Zappe D
    J Clin Hypertens (Greenwich); 2012 May; 14(5):299-306. PubMed ID: 22533656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of sympathetic nervous system in sodium-induced nocturnal hypertension.
    Okuguchi T; Osanai T; Kamada T; Kimura M; Takahashi K; Okumura K
    J Hypertens; 1999 Jul; 17(7):947-57. PubMed ID: 10419068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women.
    Mirza FS; Ong P; Collins P; Okamura K; Gerhard-Herman M; Williams GH; Seely EW
    Menopause; 2008; 15(1):44-50. PubMed ID: 18182939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption.
    Fukuda M; Wakamatsu-Yamanaka T; Mizuno M; Miura T; Tomonari T; Kato Y; Ichikawa T; Miyagi S; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F953-7. PubMed ID: 21865265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects.
    Jiang S; Mao G; Zhang S; Hong X; Tang G; Li Z; Liu X; Zhang Y; Wang B; Xu X; Wang X
    Clin Pharmacol Ther; 2005 Sep; 78(3):239-48. PubMed ID: 16153395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
    Parving HH; Lehnert H; Bröchner-Mortensen J; Gomis R; Andersen S; Arner P;
    N Engl J Med; 2001 Sep; 345(12):870-8. PubMed ID: 11565519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hypotensive, natriuretic, and hormonal effects of nifedipine in salt-sensitive and salt-resistant black normotensive and hypertensive subjects.
    Damasceno A; Santos A; Pestana M; Serrão P; Caupers P; Soares-da-Silva P; Polónia J
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):346-53. PubMed ID: 10470991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism.
    Stokes GS; Monaghan JC; Ryan M; Woodward M
    J Hypertens; 2001 Jun; 19(6):1161-5. PubMed ID: 11403366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
    Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
    Am J Hypertens; 2002 May; 15(5):389-93. PubMed ID: 12022239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects.
    Bankir L; Bochud M; Maillard M; Bovet P; Gabriel A; Burnier M
    Hypertension; 2008 Apr; 51(4):891-8. PubMed ID: 18316653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
    Chrysant SG; Weder AB; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Hamilton BP; Lewin AJ; Mennella RF; Kirkegaard LW; Weir MR; Weinberger MH
    Am J Hypertens; 2000 Nov; 13(11):1180-8. PubMed ID: 11078178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.
    Gartenmann AC; Fossali E; von Vigier RO; Simonetti GD; Schmidtko J; Edefonti A; Bianchetti MG
    Kidney Int; 2003 Oct; 64(4):1450-4. PubMed ID: 12969165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension].
    Hagino T; Abe K; Tsunoda K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):133-40. PubMed ID: 1588765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.